Of the 300 people polled by the firm, 40 percent said they smoked cigarettes at least weekly before beginning a GLP-1 drug, but that number dropped 24 percent after they began treatment. E-cigarette usage also nearly halved from 30 percent to 16 percent.
More than half of the Morgan Stanley respondents said they started drinking less after they began one of the medications, and between 14 and 18 percent reported curbing their alcohol intake entirely.
[
add
]
[
|
|
...
]